Page last updated: 2024-08-23

enoximone and Thrombopenia

enoximone has been researched along with Thrombopenia in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19902 (66.67)18.7374
1990's1 (33.33)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Atherton, B; Chatterjee, K; Curran, D; Kereiakes, A; Kereiakes, D; Parmley, WW; Spangenberg, R1
Huettemann, E; Reinhart, K; Sakka, SG1
Tommaso, CL1

Reviews

1 review(s) available for enoximone and Thrombopenia

ArticleYear
Non-glycoside, non-catecholamine inotropic agents in the treatment of congestive heart failure.
    The American journal of medicine, 1986, Feb-28, Volume: 80, Issue:2B

    Topics: Administration, Oral; Aminopyridines; Amrinone; Arrhythmias, Cardiac; Calcium; Cardiac Output; Cardiotonic Agents; Cyclic AMP; Dose-Response Relationship, Drug; Enoximone; Heart Failure; Hemodynamics; Humans; Imidazoles; Injections, Intravenous; Milrinone; Physical Exertion; Pyridones; Thrombocytopenia; Time Factors

1986

Other Studies

2 other study(ies) available for enoximone and Thrombopenia

ArticleYear
Intravenous and oral MDL 17043 (a new inotrope-vasodilator agent) in congestive heart failure: hemodynamic and clinical evaluation in 38 patients.
    Journal of the American College of Cardiology, 1984, Volume: 4, Issue:5

    Topics: Administration, Oral; Aged; Blood Pressure; Cardiotonic Agents; Enoximone; Female; Heart Failure; Hemodynamics; Humans; Imidazoles; Infusions, Parenteral; Male; Middle Aged; Nausea; Pulmonary Wedge Pressure; Stroke Volume; Thrombocytopenia; Vascular Resistance

1984
Acute left ventricular dysfunction and subarachnoid hemorrhage.
    Journal of neurosurgical anesthesiology, 1999, Volume: 11, Issue:3

    Topics: Acute Disease; Blood Pressure; Blood Volume; Cardiac Output; Cardiotonic Agents; Central Venous Pressure; Echocardiography, Transesophageal; Electrocardiography; Enoximone; Extravascular Lung Water; Female; Humans; Middle Aged; Stroke Volume; Subarachnoid Hemorrhage; Thrombocytopenia; Treatment Outcome; Vasoconstrictor Agents; Ventricular Dysfunction, Left

1999